- Home
- IOBT vs ACCS Comparison
IOBT vs ACCS Comparison
Compare IOBT & ACCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- ACCS
- Stock Information
- Founded
- IOBT 2014
- ACCS 1988
- Country
- IOBT Denmark
- ACCS United States
- Employees
- IOBT N/A
- ACCS N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- ACCS Publishing
- Sector
- IOBT Health Care
- ACCS Consumer Discretionary
- Exchange
- IOBT Nasdaq
- ACCS Nasdaq
- Market Cap
- IOBT 50.5M
- ACCS 42.6M
- IPO Year
- IOBT 2021
- ACCS N/A
- Fundamental
- Price
- IOBT $0.87
- ACCS $9.51
- Analyst Decision
- IOBT Buy
- ACCS Strong Buy
- Analyst Count
- IOBT 4
- ACCS 1
- Target Price
- IOBT $3.50
- ACCS $14.00
- AVG Volume (30 Days)
- IOBT 7.4M
- ACCS 8.2K
- Earning Date
- IOBT 11-07-2025
- ACCS 11-11-2025
- Dividend Yield
- IOBT N/A
- ACCS N/A
- EPS Growth
- IOBT N/A
- ACCS N/A
- EPS
- IOBT N/A
- ACCS N/A
- Revenue
- IOBT N/A
- ACCS $22,562,000.00
- Revenue This Year
- IOBT N/A
- ACCS $0.03
- Revenue Next Year
- IOBT N/A
- ACCS $11.45
- P/E Ratio
- IOBT N/A
- ACCS N/A
- Revenue Growth
- IOBT N/A
- ACCS 26.44
- 52 Week Low
- IOBT $0.32
- ACCS $7.79
- 52 Week High
- IOBT $2.79
- ACCS $13.35
- Technical
- Relative Strength Index (RSI)
- IOBT 47.19
- ACCS 35.31
- Support Level
- IOBT $0.62
- ACCS $9.40
- Resistance Level
- IOBT $1.23
- ACCS $9.99
- Average True Range (ATR)
- IOBT 0.14
- ACCS 0.41
- MACD
- IOBT 0.06
- ACCS -0.02
- Stochastic Oscillator
- IOBT 47.74
- ACCS 15.84
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About ACCS ACCESS Newswire Inc.
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.